Woodcock defends FDA's response to Omicron before Senate health committee
In what may be Janet Woodcock’s final congressional hearing as the head of the FDA, she once again offered a candid description of the difficulties of battling the current Omicron outbreak.
Speaking through two masks alongside other CDC, NIH and HHS leaders, Woodcock compared the current pandemic to a natural disaster, adding, “I don’t think it will last a really long time.”
“I think we need to focus on continuity of operations for hospitals,” she said in response to questions from Sen. Mike Braun (R-IN) at the Senate Health, Education, Labor and Pensions Committee meeting on Tuesday. “I think it’s hard to process what’s actually happening right now, which is that most people are going to get Covid.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.